The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $80.86

Today's change+0.70 +0.87%
Updated February 23 4:01 PM EST. Delayed by at least 15 minutes.
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $80.86

Today's change+0.70 +0.87%
Updated February 23 4:01 PM EST. Delayed by at least 15 minutes.

CVS Health Corp Hits New 20-day High

CVS Health Corp closed up Thursday by (U.S.)$0.70 or 0.87% to (U.S.)$80.86 and setting a new 20-day high. Over the last five days, shares have gained 1.77%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 39.46% during the last year.

Key company metrics

  • Open(U.S.) $80.22
  • Previous close(U.S.) $80.16
  • High(U.S.) $81.43
  • Low(U.S.) $80.01
  • Bid / Ask-- / --
  • YTD % change+2.47%
  • Volume6,403,537
  • Average volume (10-day)6,877,112
  • Average volume (1-month)7,489,923
  • Average volume (3-month)8,228,102
  • 52-week range(U.S.) $69.30 to (U.S.) $106.67
  • Beta0.82
  • Trailing P/E16.41×
  • P/E 1 year forward13.69×
  • Forward PEG1.32×
  • Indicated annual dividend(U.S.) $2.00
  • Dividend yield2.47%
  • Trailing EPS(U.S.) $4.93
Updated February 23 4:01 PM EST. Delayed by at least 15 minutes.
S&P TSX0.31%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue45,97144,61543,72543,215
Total other revenue--------
Total revenue45,97144,61543,72543,215
Gross profit7,6067,4927,0156,744
Total cost of revenue38,36537,12336,71036,471
Total operating expense42,97641,89941,91741,039
Selling / general / administrative4,6114,6754,6654,568
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0101542--
Other operating expenses, total--------
Operating income2,9952,7161,8082,176
Interest income (expense), net non-operating-248-258-284-288
Gain (loss) on sale of assets--------
Other--------
Income before tax2,7532,4631,5281,893
Income after tax1,7071,5429241,147
Income tax, total1,046921604746
Net income1,7071,5409241,146
Total adjustments to net income-9-6-4-6
Net income before extra. items1,7071,5419241,146
Minority interest0-10-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,6981,5359201,140
Inc. avail. to common incl. extra. items1,6981,5349201,140
Diluted net income1,6981,5349241,140
Dilution adjustment----4--
Diluted weighted average shares1,0701,0731,0751,099
Diluted EPS excluding extraordinary itemsvalue per share1.591.430.861.04
Dividends per sharevalue per share0.430.430.430.43
Diluted normalized EPSvalue per share1.591.491.161.04